home

ALNY.US | summary | financial summary | prediction chart | global stock news | news graph | volatility | components |pairs | earnings | dividends | sales | compare

Comparison for ALNY, Alnylam Pharmaceuticals Inc

The comparison is made between ALNY and the comparison stocks RMT and BME

Sales
companyrevenuegross incomeprofit marginincome before tax
HQL 29.56M 26.97M 91.24 -11.45M
RMT 2.12M 2.12M 100.0 22.0M
BME 18.29M 15.27M 83.5 8.71M

In the year ending in , Alnylam Pharmaceuticals Inc sales were $29.56 million and the highest and 189.75% higher than the average of $10.2 million After cost of goods, and selling and general costs, gross income were $26.97 million making it the highest and 210.25% higher than the average of $8.69 million The profit margin were a lot and 0.56% lower than the average of a lot

Assets
In the financial year , Alnylam Pharmaceuticals Inc net current assets were $5.05 million and 16.2% below the averarge of $6.02 million This consists of current assets, which were $5.05 million and 34.75% below the averarge of $7.73 million, less current liabilities, which were $0.0 the lowest of the comparisions and 100.0% lower than the average of $1712.19 thousand

Contributing to the current assets was Cash and Short term assets which were 0.01% making it the lowest and 100.0% lower than the average of $9.69, recievables (were 99.99% the highest of the comparisons and 88.06% higher than the average of 53.17%) and inventory (were 402.11% and above the other companies and a lot higher than the average of 0.0%) Contributing to the current liabilities were accounts payable (were nan,% and nan,% above the average of 9.79%) and short term debt (were nan,% and nan,% higher than the average of 79.73%)

As a multiple of net assets, current liabilities were 0.0% and the lowest and 100.0% lower than the average of 0.0. Current liabilities as days of sales represents were 0.0 making it the lowest and 100.0% lower than the average of 290.72.

In terms of days of sales, accounts receivables were 62.28 and 49.78% lower than the average of 124.01

Long term assets

For the year ending in , Alnylam Pharmaceuticals Inc net assets were $401.93 million making it the lowest and 27.49% lower than the average of $554.31 million This consists of current assets, which were $402.6 million and the lowest and 28.1% lower than the average of $559.98 million, less current liabilities, which were $666.96 thousand the lowest of the comparisions and 88.23% lower than the average of $5.67 million

Contributing to the total assets were Plant and Equipment (were 0.0% the same as the comparisions) and tangible assets(were 0.0% the same as the comparisions) Contributing to the total libiatilites were long term debt (were 0.0% the same as the comparisions) and

As a multiple of total assets, total liabilities were 0.17% and the lowest and 83.26% lower than the average of 0.01.

nametotal assetstotal liabscur assetscur liabsdays AR
HQL 402.6M 666.96K 5.05M 0.0 62.28
RMT 523.86M 3.36M 13.84M 3.36M 216.56
BME 596.1M 7.97M 1620.87K 60.69K 31.46

Plots

``` ```